Ukungacoceki kweOseltamivir
| HAYI. | Ulwakhiwo | CAS | Ubunyulu |
| ASTW-1 | 204254-96-6 | ≧95% | |
| ASTW-2 | ≧95% | ||
| ASTW-3 | 347378-74-9 | ≧95% | |
| ASTW-4 | 1266663-89-1 | ≧95% | |
| ASTW-5 | 1533519-97-9 | ≧95% | |
| ASTW-6 | ≧95% | ||
| ASTW-7 | ≧95% | ||
| ASTW-8 (Oseltamivir EP Ukungcola A) | ≧95% | ||
| ASTW-9 (Oseltamivir EP Ukungcola B) | ≧95% | ||
| ASTW-10 (Oseltamivir EP Ukungcola C) | ≧95% | ||
| ASTW-11 (Oseltamivir EP Ukungcola D) | 1346604-18-9 | ≧95% | |
| ASTW-12 (Oseltamivir EP Ukungcola E) | 208720-78-9 | ≧95% | |
| ASTW-13 (Oseltamivir EP Ukungcola F) | 1052063-37-2 | ≧95% | |
| ASTW-14 (Oseltamivir EP Ukungcola G) | ≧95% | ||
| ASTW-15 (Oseltamivir异构体1) | ≧95% | ||
| ASTW-16 (Oseltamivir异构体2) | ≧95% | ||
| ASTW-17 (Oseltamivir异构体3) | ≧95% | ||
| ASTW-18 (Oseltamivir异构体4) | ≧95% | ||
| ASTW-19 (Oseltamivir异构体5) | ≧95% | ||
| ASTW-20 (Oseltamivir异构体6) | ≧95% | ||
| ASTW-21 (Oseltamivir异构体7) | ≧95% | ||
| ASTW-22 (OseltamivirImpurityK)
| ≧95% | ||
| ASTW-23 (OseltamivirImpurityI)
| ≧95% | ||
| ASTW-24
| ≧95% | ||
| ASTW-25
| ≧95% | ||
| ASTW-26
| ≧95% | ||
| ASTW-27
| ≧95% |
Ulwazi lweNkampani
√ Amava apheleleyo omaleko wolawulo kumzi-mveliso kunye namagcisa anezakhono abalandeli; √ Umgangatho usoloko uyingqwalasela yethu ephezulu, inkqubo yeQC eQinisekileyo; √ Iminyaka eli-11 yamava eqela lokuthengisa kumazwe angaphandle; √ ilebhu yeR&D eZimeleyo; √ Iindibano zocweyo zeGMP ezimbini ezityikityiweyo zexesha elide; √ Imithombo etyebileyo yeefektri ezininzi ezingasebenziyo ukulungiselela iprojekthi elungelelanisiweyo; √ Iqela elisebenzayo eliSebenzayo ngokuSebenzayo ngendlela engaguqukiyo.
